Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HCV treatment initiation dropped by 31% from March to April 2020 and remained low throughout the year.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
COVID-19 vaccines are highly effective, but people with a low CD4 count or detectable viral load are at risk for poor response.
Earlier studies on safety measures in schools were often conducted in affluent and ethnically homogeneous neighborhoods.
Paxlovid dramatically reduced the risk of severe illness and death, but it must be started soon after developing symptoms.
NIH-supported research will track effects of coronavirus infection on children over three years.
Robert Califf headed the Food and Drug Administration for 10 months under Obama. Will he manage to implement his ideas this time around?
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Study shows just one snapshot of the impact of COVID-19 on the health and access to care among people living with HIV.
Inner ear infection could explain hearing and balance issues in some people with COVID-19.
Immunocompromised people and those with underlying health conditions can benefit from additional shots.
The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.
Vaccine effectiveness for children ages 5 to 11 was 91%, and serious side effects are rare.
MIS-C is a rare but life-threatening complication in which a hyperactive immune system attacks a child’s body.
People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.
CDC study shows vaccine-induced immunity is stronger, but others found post-infection immunity more protective.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.